Cargando…

Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity

The blood–brain barrier (BBB) is a formidable obstacle to the delivery of therapeutics to the brain. Antibodies that bind transferrin receptor (TfR), which is enriched in brain endothelial cells, have been shown to cross the BBB and are being developed as fusion proteins to deliver therapeutic cargo...

Descripción completa

Detalles Bibliográficos
Autores principales: Haqqani, Arsalan S., Thom, George, Burrell, Matthew, Delaney, Christie E., Brunette, Eric, Baumann, Ewa, Sodja, Caroline, Jezierski, Anna, Webster, Carl, Stanimirovic, Danica B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175443/
https://www.ncbi.nlm.nih.gov/pubmed/29877588
http://dx.doi.org/10.1111/jnc.14482
_version_ 1783361514013458432
author Haqqani, Arsalan S.
Thom, George
Burrell, Matthew
Delaney, Christie E.
Brunette, Eric
Baumann, Ewa
Sodja, Caroline
Jezierski, Anna
Webster, Carl
Stanimirovic, Danica B.
author_facet Haqqani, Arsalan S.
Thom, George
Burrell, Matthew
Delaney, Christie E.
Brunette, Eric
Baumann, Ewa
Sodja, Caroline
Jezierski, Anna
Webster, Carl
Stanimirovic, Danica B.
author_sort Haqqani, Arsalan S.
collection PubMed
description The blood–brain barrier (BBB) is a formidable obstacle to the delivery of therapeutics to the brain. Antibodies that bind transferrin receptor (TfR), which is enriched in brain endothelial cells, have been shown to cross the BBB and are being developed as fusion proteins to deliver therapeutic cargos to brain targets. Various antibodies have been developed for this purpose and their in vivo evaluation demonstrated that either low affinity or monovalent receptor binding re‐directs their transcellular trafficking away from lysosomal degradation and toward improved exocytosis on the abluminal side of the BBB. However, these studies have been performed with antibodies that recognize different TfR epitopes and have different binding characteristics, preventing inter‐study comparisons. In this study, the efficiency of transcytosis in vitro and intracellular trafficking in endosomal compartments were evaluated in an in vitro BBB model for affinity variants (K (d) from 5 to174 nM) of the rat TfR‐binding antibody, OX26. Distribution in subcellular fractions of the rat brain endothelial cells was determined using both targeted quantitative proteomics‐selected reaction monitoring and fluorescent imaging with markers of early‐ and late endosomes. The OX26 variants with affinities of 76 and 108 nM showed improved trancytosis (P(app) values) across the in vitro BBB model compared with a 5 nM OX26. Although ~40% of the 5 nM OX26 and ~35% of TfR co‐localized with late‐endosome/lysosome compartment, 76 and 108 nM affinity variants showed lower amounts in lysosomes and a predominant co‐localization with early endosome markers. The study links bivalent TfR antibody affinity to mechanisms of sorting and trafficking away from late endosomes and lysosomes, resulting in improvement in their transcytosis efficiency. OPEN PRACTICES: [Image: see text] Open Science: This manuscript was awarded with the Open Materials Badge. For more information see: https://cos.io/our-services/open-science-badges/ [Image: see text] Cover Image for this issue: doi: 10.1111/jnc.14193.
format Online
Article
Text
id pubmed-6175443
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61754432018-10-19 Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity Haqqani, Arsalan S. Thom, George Burrell, Matthew Delaney, Christie E. Brunette, Eric Baumann, Ewa Sodja, Caroline Jezierski, Anna Webster, Carl Stanimirovic, Danica B. J Neurochem ORIGINAL ARTICLES The blood–brain barrier (BBB) is a formidable obstacle to the delivery of therapeutics to the brain. Antibodies that bind transferrin receptor (TfR), which is enriched in brain endothelial cells, have been shown to cross the BBB and are being developed as fusion proteins to deliver therapeutic cargos to brain targets. Various antibodies have been developed for this purpose and their in vivo evaluation demonstrated that either low affinity or monovalent receptor binding re‐directs their transcellular trafficking away from lysosomal degradation and toward improved exocytosis on the abluminal side of the BBB. However, these studies have been performed with antibodies that recognize different TfR epitopes and have different binding characteristics, preventing inter‐study comparisons. In this study, the efficiency of transcytosis in vitro and intracellular trafficking in endosomal compartments were evaluated in an in vitro BBB model for affinity variants (K (d) from 5 to174 nM) of the rat TfR‐binding antibody, OX26. Distribution in subcellular fractions of the rat brain endothelial cells was determined using both targeted quantitative proteomics‐selected reaction monitoring and fluorescent imaging with markers of early‐ and late endosomes. The OX26 variants with affinities of 76 and 108 nM showed improved trancytosis (P(app) values) across the in vitro BBB model compared with a 5 nM OX26. Although ~40% of the 5 nM OX26 and ~35% of TfR co‐localized with late‐endosome/lysosome compartment, 76 and 108 nM affinity variants showed lower amounts in lysosomes and a predominant co‐localization with early endosome markers. The study links bivalent TfR antibody affinity to mechanisms of sorting and trafficking away from late endosomes and lysosomes, resulting in improvement in their transcytosis efficiency. OPEN PRACTICES: [Image: see text] Open Science: This manuscript was awarded with the Open Materials Badge. For more information see: https://cos.io/our-services/open-science-badges/ [Image: see text] Cover Image for this issue: doi: 10.1111/jnc.14193. John Wiley and Sons Inc. 2018-08-16 2018-09 /pmc/articles/PMC6175443/ /pubmed/29877588 http://dx.doi.org/10.1111/jnc.14482 Text en © 2018 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle ORIGINAL ARTICLES
Haqqani, Arsalan S.
Thom, George
Burrell, Matthew
Delaney, Christie E.
Brunette, Eric
Baumann, Ewa
Sodja, Caroline
Jezierski, Anna
Webster, Carl
Stanimirovic, Danica B.
Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity
title Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity
title_full Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity
title_fullStr Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity
title_full_unstemmed Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity
title_short Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity
title_sort intracellular sorting and transcytosis of the rat transferrin receptor antibody ox26 across the blood–brain barrier in vitro is dependent on its binding affinity
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175443/
https://www.ncbi.nlm.nih.gov/pubmed/29877588
http://dx.doi.org/10.1111/jnc.14482
work_keys_str_mv AT haqqaniarsalans intracellularsortingandtranscytosisoftherattransferrinreceptorantibodyox26acrossthebloodbrainbarrierinvitroisdependentonitsbindingaffinity
AT thomgeorge intracellularsortingandtranscytosisoftherattransferrinreceptorantibodyox26acrossthebloodbrainbarrierinvitroisdependentonitsbindingaffinity
AT burrellmatthew intracellularsortingandtranscytosisoftherattransferrinreceptorantibodyox26acrossthebloodbrainbarrierinvitroisdependentonitsbindingaffinity
AT delaneychristiee intracellularsortingandtranscytosisoftherattransferrinreceptorantibodyox26acrossthebloodbrainbarrierinvitroisdependentonitsbindingaffinity
AT brunetteeric intracellularsortingandtranscytosisoftherattransferrinreceptorantibodyox26acrossthebloodbrainbarrierinvitroisdependentonitsbindingaffinity
AT baumannewa intracellularsortingandtranscytosisoftherattransferrinreceptorantibodyox26acrossthebloodbrainbarrierinvitroisdependentonitsbindingaffinity
AT sodjacaroline intracellularsortingandtranscytosisoftherattransferrinreceptorantibodyox26acrossthebloodbrainbarrierinvitroisdependentonitsbindingaffinity
AT jezierskianna intracellularsortingandtranscytosisoftherattransferrinreceptorantibodyox26acrossthebloodbrainbarrierinvitroisdependentonitsbindingaffinity
AT webstercarl intracellularsortingandtranscytosisoftherattransferrinreceptorantibodyox26acrossthebloodbrainbarrierinvitroisdependentonitsbindingaffinity
AT stanimirovicdanicab intracellularsortingandtranscytosisoftherattransferrinreceptorantibodyox26acrossthebloodbrainbarrierinvitroisdependentonitsbindingaffinity